Cell Biology: The mother of all endocytosis
When Robert Hooke first peered down his microscope into a piece of cork, he imagined that the living world was divided into individual cells, like those lived in by the monks of his day (Hooke, 1665). Despite the survival of Hooke’s inapt analogy, the cell is not a static monastery room. The plasma membrane that surrounds the cell can, for example, be absorbed by the cell in a process called endocytosis. A number of different endocytosis pathways have been identified by researchers (Doherty and McMahon, 2009), and with more than 80,000 papers published on the subject, it is surprising that is something left to be categorized. Now, however, in a pair of papers in eLife, Donald Hilgemann of the University of Texas Southwestern Medical Center (UTSW) and co-workers describe the mechanisms responsible for a form of endocytosis in which about half of the plasma membrane is absorbed by the cell (Hilgemann et al., 2013; Lin et al., 2013). This form of endocytosis, which is called massive endocytosis, was discovered at UTSW a few years ago (Fine et al., 2011; Hilgemann and Fine, 2011).
Lipid bilayer membranes are nature’s choice for defining temporary borders. The walls of animal cells are downright thin, comprised of lipid bilayers only 40 Å across, and they form all manner of shapes along energetically defined contours. Endocytosis requires energy, and the creation of a closed spherical vesicle from a flat bilayer takes an estimated 200–250 kcal per mole of vesicle (Helfrich, 1973). The most well-established form of endocytosis involves a scaffold protein called clathrin coupling to the membrane, with the energy needed to drive the process coming from ATP (Kirchhausen, 2012), but a number of other mechanisms have been discovered. Endocytosis is studied by the many forms of light microscopy, and in greater detail by electron microscopy, but no single method directly assays all aspects of the process as it occurs in native membranes.
One live assay of endocytosis is called capacitance recording, which is an extension of patch clamp methodology. This technique allows extremely small changes in the area of the plasma membrane (∼0.01 µm2) to be detected as individual events and precise measurements to be made of net membrane loss or uptake during exocytosis or endocytosis (Neher and Marty, 1982). Now, in a refreshingly original study, Donald Hilgemann and co-workers at UTSW and Cornell—Michael Fine, Maurine Linder, Benjamin Jennings and Mei-Jung Lin—have used a combination of capacitance recording and other techniques to study the mechanism responsible for the massive endocytosis that occurs after a sudden influx of calcium ions into cells called BHK fibroblasts (Hilgemann et al., 2013).
Massive endocytosis is preceded by depolarization of the inner membrane of the mitochondria and/or the formation of pores called permeability transition pores: both of these processes allow coenzyme A (a small molecule i.e., required for the oxidation of pyruvate and fatty acids) to move from inside the mitochondria to the cytoplasm of the cell. Experimentally, this is accomplished by various mitochondrial insults, such as increasing the concentration of calcium ions inside the cell or poisoning the electron transport chain. Inhibition of calcium uptake blocks massive endocytosis.
The key finding is that the movement of coenzyme A (CoA) into the cytoplasm leads to the synthesis of acyl-CoA, which acts as a substrate for an enzyme, DHHC5, that transfers the fatty acid group called palmitoyl to proteins and thus anchors these proteins to the plasma membrane. In short, mitochondrial damage and the increased availability of substrates for DHHC5 unleash the proteins that initiate endocytosis. One such protein, flotillin, was previously shown to be palmitoylated by DHHC5 (Li et al., 2012). However, proteins are not the only participants in massive endocytosis: cholesterol and PIP2 (a phospholipid i.e., found in the cell membrane) can also induce massive endocytosis minutes after the sudden increase in the concentration of calcium ions has subsided (Lariccia et al., 2011).
In the second paper, Hilgemann, Lin, Fine and other co-workers—Jui-Yun Lu and Sandra Hoffman (both UTSW) and Gary Frazier (University of Texas at Dallas)—investigate reperfusion injury, the damage caused when blood supply returns to a tissue after a period of ischemia, in cardiac muscle cells (Lin et al., 2013; Figure 1). Reoxygenation after anoxia, such as occurs during a heart attack, results in massive endocytosis. Using protocols that raise the levels of calcium or acyl-CoA inside the cell, the UTSW team infers that opening the permeability transition pores, activating protein kinase C, and triggering a calcium-dependent mechanism can all induce massive endocytosis. However, massive endocytosis is strongly inhibited in mice lacking DHHC5, resulting in significantly preserved right ventricular contractile function. Finally, Lin et al. show that a diverse range of protein targets undergo palmitoylation (that is, attachment of the fatty acid group, palmitoyl) after reperfusion injury. This most consequential finding of a reduction of massive endocytosis and the preservation of contractility in DHHC5 knockout mice suggests a potential new approach to ameliorate the problem of reperfusion injury.
Although Hilgemann and co-workers tip their hat to the possibility that massive endocytosis can be an ongoing process, the hypothesis mainly rests on dire cellular Ca2+ leak conditions, such as those that occur with membrane damage. This sort of large cytoplasmic calcium entry is widely associated with fast massive exocytosis, presumably required for the resealing of membranes (McNeil and Steinhardt, 2003). The link between initial exocytosis followed by endocytosis via vesicles larger than coated vesicles was described in pituitary cells (Thomas et al., 1994). As in those cells, exocytosis in fibroblasts occurs in the first few seconds after a large calcium increase in fibroblasts and is followed by massive endocytosis, but the initial exocytosis is not observed in cardiac muscle cells (Lin et al., 2013). This suggests that these cells lack the pool of vesicles used in the fast exocytosis phase. The identities of these exocytotic or endocytic vesicles are not established.
Other questions remain. Is massive endocytosis an evolutionarily primitive form of endocytosis—the mother of all endocytosis—that separates protein- and cholesterol-rich membranes? Does coenzyme A evoke a regulatory network linking mitochondria to numerous cytoplasmic processes? The understanding of massive endocytosis would be solidified by live tissue imaging of acyl-CoA levels or DHHC5 activity, but these will require the invention of new indicator methods.
One mystery is the role of protein kinase C in massive endocytosis. Since this enzyme phosphorylates phospholemman (a small membrane protein i.e., involved in ion transport), the question arises as to the functional consequence of phosphorylation before or after palmitoylation. Comparison of all palmitoylated proteins before and after massive endocytosis, and the examination of potential newly formed membrane phases, will help illuminate why such massive endocytosis occurs. Perhaps even more important is to follow the fate of such cells over longer durations—that is, is massive endocytosis simply a cellular death throe, or is it a useful adaptation?
References
-
Mechanisms of endocytosisAnnu Rev Biochem 78:857–902.https://doi.org/10.1146/annurev.biochem.78.081307.110540
-
Elastic properties of lipid bilayers: theory and possible experimentsZ Naturforsch C 28:693–703.
-
BookMicrographia: or, some physiological descriptions of minute bodies made by magnifying glasses. With observations and inquiries thereuponLondon: Printed by J Martyn and J Allestry.
-
Plasma membrane disruption: repair, prevention, adaptationAnnu Rev Cell Dev Biol 19:697–731.https://doi.org/10.1146/annurev.cellbio.19.111301.140101
Article and author information
Author details
Acknowledgements
I thank Don Hilgemann (UTSW) and Tommy Kirchhausen (Harvard Medical School) for helpful discussions.
Publication history
Copyright
© 2013, Clapham
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,388
- views
-
- 124
- downloads
-
- 3
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Structural Biology and Molecular Biophysics
- Cell Biology
In fibroblasts, large Ca transients activate massive endocytosis (MEND) that involves membrane protein palmitoylation subsequent to mitochondrial permeability transition pore (PTP) openings. Here, we characterize this pathway in cardiac muscle. Myocytes with increased expression of the acyl transferase, DHHC5, have decreased Na/K pump activity. In DHHC5-deficient myocytes, Na/K pump activity and surface area/volume ratios are increased, the palmitoylated regulatory protein, phospholemman (PLM), and the cardiac Na/Ca exchanger (NCX1) show greater surface membrane localization, and MEND is inhibited in four protocols. Both electrical and optical methods demonstrate that PTP-dependent MEND occurs during reoxygenation of anoxic hearts. Post-anoxia MEND is ablated in DHHC5-deficient hearts, inhibited by cyclosporine A (CsA) and adenosine, promoted by staurosporine (STS), reduced in hearts lacking PLM, and correlates with impaired post-anoxia contractile function. Thus, the MEND pathway appears to be deleterious in severe oxidative stress but may constitutively contribute to cardiac sarcolemma turnover in dependence on metabolic stress.
-
- Structural Biology and Molecular Biophysics
Peroxisome proliferator-activated receptor gamma (PPARγ) is a nuclear receptor transcription factor that regulates gene expression programs in response to ligand binding. Endogenous and synthetic ligands, including covalent antagonist inhibitors GW9662 and T0070907, are thought to compete for the orthosteric pocket in the ligand-binding domain (LBD). However, we previously showed that synthetic PPARγ ligands can cooperatively cobind with and reposition a bound endogenous orthosteric ligand to an alternate site, synergistically regulating PPARγ structure and function (Shang et al., 2018). Here, we reveal the structural mechanism of cobinding between a synthetic covalent antagonist inhibitor with other synthetic ligands. Biochemical and NMR data show that covalent inhibitors weaken—but do not prevent—the binding of other ligands via an allosteric mechanism, rather than direct ligand clashing, by shifting the LBD ensemble toward a transcriptionally repressive conformation, which structurally clashes with orthosteric ligand binding. Crystal structures reveal different cobinding mechanisms including alternate site binding to unexpectedly adopting an orthosteric binding mode by altering the covalent inhibitor binding pose. Our findings highlight the significant flexibility of the PPARγ orthosteric pocket, its ability to accommodate multiple ligands, and demonstrate that GW9662 and T0070907 should not be used as chemical tools to inhibit ligand binding to PPARγ.